Most sold healthcare stocks in Q4 2019
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2019, measured as net reductions in reported share positions from Q3 2019 into Q4 2019. Notable reductions at the top of this list include ASTRAZENECA PLC-SPONS ADR (AZN), HOLOGIC INC (HOLX), TAKEDA PHARMACEUTIC-SP ADR (TAK), JOHNSON & JOHNSON (JNJ). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLC-SPONS ADR | -10,161,310 | -$244.81M | 0 | 1 | 1 | 0 | 2 |
| HOLX | HOLOGIC INC | -9,682,163 | -$476.34M | 0 | 1 | 2 | 0 | 3 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -9,157,218 | -$146.09M | 0 | 1 | 1 | 1 | 2 |
| JNJ | JOHNSON & JOHNSON | -4,897,037 | -$280.56M | 1 | 5 | 7 | 1 | 17 |
| AKBA | AKEBIA THERAPEUTICS INC | -4,804,900 | $42.05M | 0 | 1 | 1 | 0 | 3 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -3,389,321 | $208.55M | 0 | 1 | 2 | 1 | 5 |
| CNC | CENTENE CORP | -2,947,357 | $157.78M | 0 | 1 | 3 | 0 | 5 |
| CVS | CVS HEALTH CORP | -2,580,240 | $263.03M | 5 | 4 | 6 | 0 | 16 |
| IQV | IQVIA HOLDINGS INC | -2,425,202 | -$334.73M | 0 | 0 | 3 | 0 | 4 |
| SNY | SANOFI-ADR | -1,813,472 | $144.62M | 0 | 1 | 1 | 0 | 3 |
| MRNA | MODERNA INC | -1,356,026 | -$9.50M | 0 | 0 | 1 | 0 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | -1,340,946 | -$10.53M | 0 | 0 | 1 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -1,040,051 | -$122.60M | 1 | 0 | 4 | 1 | 5 |
| GOSS | GOSSAMER BIO INC | -967,171 | -$15.87M | 0 | 0 | 0 | 1 | 0 |
| ILMN | ILLUMINA INC | -953,438 | -$242.70M | 1 | 2 | 1 | 0 | 4 |
| PRGO | Perrigo Company PLC | -863,269 | -$73.70M | 0 | 1 | 2 | 1 | 3 |
| HQY | HEALTHEQUITY INC | -857,812 | -$47.49M | 0 | 0 | 1 | 0 | 1 |
| NVST | ENVISTA HOLDINGS CORP | -814,828 | -$20.72M | 0 | 0 | 1 | 1 | 1 |
| ELV | ELEVANCE HEALTH INC | -787,986 | $584.76M | 2 | 2 | 4 | 1 | 11 |
| LLY | ELI LILLY & CO | -754,373 | $91.77M | 1 | 2 | 2 | 1 | 5 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -646,010 | -$106.52M | 0 | 0 | 1 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | -637,786 | -$53.27M | 0 | 0 | 1 | 1 | 1 |
| TNDM | TANDEM DIABETES CARE INC | -608,727 | -$35.47M | 0 | 0 | 1 | 0 | 1 |
| REGN | REGENERON PHARMACEUTICALS | -596,318 | $41.51M | 0 | 1 | 3 | 0 | 4 |
| CTLT | CATALENT INC | -586,262 | -$13.64M | 0 | 1 | 2 | 1 | 3 |
| GMAB | GENMAB A/S -SP ADR | -547,078 | -$9.54M | 0 | 0 | 2 | 0 | 2 |
| ANAB | ANAPTYSBIO INC | -483,805 | -$18.66M | 1 | 0 | 0 | 1 | 1 |
| OSUR | ORASURE TECHNOLOGIES INC | -426,290 | -$838.00K | 0 | 0 | 1 | 0 | 1 |
| EDIT | EDITAS MEDICINE INC | -403,021 | $26.99M | 1 | 0 | 1 | 0 | 3 |
| AMGN | AMGEN INC | -389,778 | $140.37M | 1 | 2 | 4 | 0 | 8 |
| EHC | ENCOMPASS HEALTH CORP | -359,922 | -$22.62M | 0 | 1 | 0 | 1 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | -348,078 | -$26.22M | 0 | 0 | 0 | 1 | 0 |
| LNTH | LANTHEUS HOLDINGS INC | -230,100 | -$12.17M | 0 | 0 | 1 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | -220,210 | -$10.24M | 0 | 0 | 1 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | -217,189 | $11.38M | 1 | 1 | 3 | 0 | 5 |
| EW | EDWARDS LIFESCIENCES CORP | -206,834 | -$16.27M | 3 | 4 | 2 | 0 | 10 |
| RVNC | REVANCE THERAPEUTICS INC | -198,900 | -$398.00K | 0 | 0 | 1 | 0 | 1 |
| LGND | LIGAND PHARMACEUTICALS | -198,225 | -$14.88M | 0 | 0 | 1 | 0 | 1 |
| HAE | HAEMONETICS CORP/MASS | -187,084 | -$51.02M | 0 | 0 | 1 | 0 | 1 |
| WAT | WATERS CORP | -177,011 | $16.26M | 0 | 0 | 2 | 1 | 2 |
| ABUS | ARBUTUS BIOPHARMA CORP | -168,312 | -$257.00K | 0 | 0 | 0 | 1 | 0 |
| GMED | GLOBUS MEDICAL INC - A | -167,386 | -$192.00K | 0 | 0 | 1 | 0 | 1 |
| STE | STERIS PLC | -165,858 | -$23.84M | 0 | 0 | 1 | 0 | 1 |
| ADUS | ADDUS HOMECARE CORP | -159,020 | -$12.61M | 0 | 0 | 0 | 1 | 0 |
| SAGE | SAGE THERAPEUTICS INC | -152,875 | -$28.98M | 1 | 0 | 0 | 1 | 1 |
| ALLK | ALLAKOS INC | -151,500 | -$11.72M | 0 | 0 | 1 | 0 | 1 |
| ESPR | ESPERION THERAPEUTICS INC | -141,900 | -$5.20M | 0 | 0 | 0 | 1 | 0 |
| NVS | NOVARTIS AG-SPONSORED ADR | -131,126 | $242.60M | 1 | 3 | 3 | 0 | 10 |
| AGIO | AGIOS PHARMACEUTICALS INC | -121,000 | -$3.92M | 0 | 0 | 0 | 1 | 0 |
| NEO | NEOGENOMICS INC | -119,500 | -$2.29M | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q4 2019
What are the most sold Healthcare stocks in Q4 2019?
The most sold healthcare stocks in Q4 2019 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2019, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2019?
Among filers in this sector, net reductions were largest in companies such as ASTRAZENECA PLC-SPONS ADR (AZN), HOLOGIC INC (HOLX), TAKEDA PHARMACEUTIC-SP ADR (TAK), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2019).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.